Successfully completes phase 1 clinical trialFebruary 1, 2021|By sh.koizumi@gmail.comAvilex Pharma successfully completes its phase 1 clinical trial of AVLX-144 – a potentially game-changing treatment for acute neurological conditions PrevNext
